First comes darkness, then comes fear Eve Duncan is back! Blockbuster New York Times bestselling author Iris Johansen's thrilling Blood Game brings Eve closer to discovering her daughter's killer...and into a web of danger from which she may not be able to escape... Eve Duncan returns in a thriller that pits her against the most evil mind she has ever encountered: a ruthless killer who taunts her with his every move...and who has a special affinity for blood. When a Georgia senator's daughter is found murdered, and her body drained of blood, Eve Duncan is drawn into the web of Kevin Jelak—a serial murderer who is on Eve's short list of killers who might know something about her missing daughter Bonnie. When a goblet of blood is found in Eve's refrigerator, she knows the taunting is over...and the games have begun. As Eve and Jelak engage in a dance of death, Eve must call upon those she loves and trusts the most...even if it means bringing them into the game as well.
This book gathers together the collected wisdom of an experienced group of practitioners from the world of blood conservation including surgeons, anaesthetists, haematologists, transfusion specialists, microbiologists, and legal advisors. Topics included are: an historical overview, transfusion-transmitted diseases, changing demographics and the projected impact on blood supplies, who needs transfusion, practicalities and tips - how to do it, the laboratory perspective, haemodilution, intra-operative cell salvage, surgical methods to minimise blood loss, anaesthetic methods to minimise blood loss, pharmacological methods to minimise blood loss, postoperative salvage, postoperative haemoglobin, cancer patients, patient consent and refusal, trauma management, patient ID and documentation, audit/clinical governance, the role of the Hospital Transfusion Team, education, national reports including European Directives, further information. Additional chapters will include pre-operative blood management, near-patient testing, the incidence and relevance of pre-operative anaemia, anaemia management in obstetrics, pre-operative anaemia in orthopaedics, haemostatic sealants, the effect of transfusion in cardiovascular surgery, transfusion alternatives.
This guidance document has been produced by the World Health Organization (WHO) to assist blood services in the development of national plans to respond to any disaster, major incident or emergency that threatens sufficiency or safety of the blood supply. Such situations can be caused by natural forces, by factors influenced by humans or directly caused by humans. This document is intended to guide the national blood service through the process of planning how to respond in a timely, controlled and appropriate way to emergencies. In the preparation of the document, WHO has tried to include the elements that blood services or providers might need to consider, providing some background on the reasons for their inclusion and guidance on different response options that may be available. The consequences of an emergency may include interruption of blood supply due to a shortage of blood donors, or to a disrupted supply of critical materials and equipment used in blood collection, component preparation and laboratory testing, resulting in reduced availability of blood and blood components. Although the demand for transfusion may decrease in some situations, transfusions continue to be necessary for clinical emergencies and for those patients reliant on long-term transfusion support. In contrast, some emergencies, for instance those resulting in multiple casualties, could lead to a rapid surge in demand for blood over a short time. The challenge is to maintain essential transfusion services as well as responding to the emergency. Preparedness, including business continuity planning, is essential for blood services to mitigate the impact of emergencies. Preparation should be underpinned by locally sensitive risk assessment using relevant data at the local or country level. However, it is not possible to predict the nature of every situation that could impact on the blood supply, and it is therefore expected that blood services will review the elements in this document as well as assessing their own situation, needs, capabilities and resources, along with any additional relevant country-specific factors, in the development of their own response plans. Planning should consider the concurrence and combinations of events and the response should be proportionate and coordinated with others. The aim is to maintain critical services and prepare for recovery. Staff training and support is key to resilience. It is acknowledged that as well as affecting the sufficiency and safety of blood supply, major incidents in countries undertaking transplantation may threaten the safety and sufficiency of the supply of other products of human origin, such as cells, tissues and organs. Increasingly, blood services are taking overall national responsibility for transplantation in their capacity as the organization responsible for the collection, processing, storage and supply of cells, tissues and organs. This approach is both sensible and appropriate, as the overall donor selection and screening processes are the same or very similar. This guidance document can therefore also be used to assist those bodies responsible for the provision of cells, tissues and organs to prepare for emergencies. Resilience to disasters and emergencies requires a commitment to the blood supply and transfusion system as an integral part of the health care system.
Containing the biographies of over one hundred black women who write horror, 100+ Black Women in Horror is a reference guide, a veritable who's who of female horror writers from the African Diaspora. It is an expansion of the original 2014 book 60 Black Women in Horror. February is African American History Month here in the United States. It is also Women in Horror Month (WiHM). This list of black women who write horror was compiled at the intersection of the two. It consists of an alphabetical listing of the women with biographies, photos, and web addresses, as well as interviews with 17 of these women and an essay by David Watson on LA Banks and Octavia Butler.
The field of HCV therapeutics continues to evolve rapidly and since the World Health Organization (WHO) issued its first Guidelines for the screening care and treatment of persons with hepatitis C infection in 2014 several new medicines have been approved by at least one stringent regulatory authority. These medicines called direct-acting antivirals (DAAs) are transforming the treatment of HCV enabling regimens that can be administered orally are of shorter duration (as short as eight weeks) result in cure rates higher than 90% and are associated with fewer serious adverse events than the previous interfere on containing regimens. WHO is updating its hepatitis C treatment guidelines to provide recommendations for the use of these new medicines. The objectives of these WHO guidelines are to provide updated evidence-based recommendations for the treatment of persons with hepatitis C infection using where possible all DAA-only combinations. The guidelines also provide recommendations on the preferred regimens based on a patient?s HCV genotype and clinical history and assess the appropriateness of continued use of certain medicines. This document also includes existing recommendations on screening for HCV infection and care of persons infected with HCV that were first issued in 2014. The key audience for these guidelines are policy-makers in low- and middle-income countries who formulate country-specific treatment guidelines and who plan infectious disease treatment programmes and services in addition to those people responsible for delivering treatment. The guidelines are appropriate for all countries including high-income countries.
Medical Conditions in the Athlete, Third Edition With Web Study Guide, equips health care providers with the information they need to develop a framework for decision making when working with injured and recovering athletes and active populations. The updated and streamlined third edition provides comprehensive medical information that assists health care providers and athletic trainers in recognizing and identifying underlying and potentially serious medical conditions that may affect their chosen course of treatment. The highly esteemed authors, Katie Walsh Flanagan and Micki Cuppett, have combined their professional skills and educational expertise to revitalize the content of Medical Conditions in the Athlete, Third Edition, with current, research-driven assessment and treatment information for medical conditions that affect the physically active population. The updated content aligns with Board of Certification (BOC) and Commission on Accreditation of Athletic Training Education (CAATE) standards. The book addresses medical conditions by body system, their mechanism of acquisition, signs, symptoms, differential diagnoses, referral, treatment, and return-to-participation criteria. The 18 comprehensive chapters are organized into three sections: Introduction to Medical Conditions, Pharmacology and Interventions, and Medical Conditions by System. Throughout the text, more than 380 updated, full-color illustrations and photographs visually enhance readers’ comprehension of anatomy, physiology, and pathophysiology. Pharmacological tables organize drugs by categories that include generic and trade names, therapeutic uses, adult dosage information, and possible adverse effects. Important terminology is highlighted throughout the chapters, and a glossary appears at the end of the text. At the beginning of the text, a Condition Finder serves as a quick reference so health care providers can easily flip to the information they need on specific conditions. Throughout the book, learning aids draw attention to important facts and figures, presented in three practical categories: • Red Flags are warning signs that health care providers should look for when working with clients. • Clinical Tips discuss information that is critically important to professionals. • Condition Highlights cover specific medical conditions common to athletes that require special attention or medical care. New to this edition is an accompanying web study guide that houses case studies corresponding to specific chapters. Each case study is followed by questions to help students apply the strategies covered in the text. Instructors who adopt the text will have access to a comprehensive collection of ancillary materials: chapter quizzes, a presentation package of slides, and an image bank that can be used to enhance presentation slides or student handouts. Medical Conditions in the Athlete, Third Edition With Web Study Guide, provides readers with research-driven assessment and treatment information for medical conditions that affect all types of athletes. It is a comprehensive textbook and an important reference for health care providers such as athletic trainers and physical therapists who work with active populations.
The new edition of this textbook integrates the history, epidemiology, pathology, pathophysiology, therapeutics, and supportive care of modern neoplastic hematopathology. Now in its sixth edition, this classic and invaluable text brings together a team of internationally renowned experts and offers in-depth coverage of the complex interface between diagnosis and therapy. The textbook is divided into five major sections, with the first four covering the spectrum of hematologic neoplasia, including chronic leukemias and related disorders, acute leukemias, myeloma and related disorders, and lymphomas, and the fifth section covering a variety of topics in supportive care. Chapters are presented in an accessible and easy-to-read layout, providing updates on the tremendous progress made in the last decade in the understanding of the nature of hematologic malignancies and their treatment. Neoplastic Diseases of the Blood, Sixth Edition is an authoritative and indispensable resource for students, trainees, and clinicians, sure to distinguish itself as the definitive reference on this subject.
Providing a concise, yet comprehensive, reference on all aspectsof industrial exposures and toxicants; this book aidstoxicologists, industrial hygienists, and occupational physiciansto investigate workplace health problems. • Updates and expands coverage with new chapterscovering regulatory toxicology, toxicity testing, physical hazards,high production volume (HPV) chemicals, and workplace druguse • Includes information on occupational and environmentalsources of exposure, mammalian toxicology, industrial hygiene,medical management and ecotoxicology • Retains a succinct chapter format that has become thehallmark for the previous editions • Distils a vast amount of information into one resourcefor both academics and professionals
